| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/25/2008 | WO2008114819A1 Novel adenine compound |
| 09/25/2008 | WO2008114817A1 Novel adenine compound |
| 09/25/2008 | WO2008114812A1 Jak inhibitor |
| 09/25/2008 | WO2008114807A1 Weekly administration of dipeptidyl peptidase inhibitors |
| 09/25/2008 | WO2008114800A2 Solid preparation comprising 2- [ [6- [ (3r) -3-amino-1-piperidinyl] -3, 4-dihydro-3-methyl-2, 4-dioxo-1 (2h) -pyrimidinyl] methyl] -4-fluorobenzonitrile |
| 09/25/2008 | WO2008114787A1 Antiviral agent |
| 09/25/2008 | WO2008114732A1 Wrinkling-preventing and -modifying agent |
| 09/25/2008 | WO2008114679A1 Bone metabolism ameliorating agent |
| 09/25/2008 | WO2008114513A1 Prophylactic and/or therapeutic agent for cardiac infarction |
| 09/25/2008 | WO2008114505A1 Eg5 inhibitor and agent for treatment of cell proliferative disease containing the same |
| 09/25/2008 | WO2008114280A1 Novel reduced dose pharmaceutical compositions of fexofenadine and pseudoephedrine |
| 09/25/2008 | WO2008114276A1 Novel oral controlled release composition of carvedilol |
| 09/25/2008 | WO2008114275A2 Anthranilic acid derivatives as anticancer agents and process for the preparation thereof |
| 09/25/2008 | WO2008114274A1 Proliposomal and liposomal compositions |
| 09/25/2008 | WO2008114157A1 Amino- pyridine derivatives as s1p1 /edg1 receptor agonists |
| 09/25/2008 | WO2008114143A1 Extended release formulations of macrolide antibiotic |
| 09/25/2008 | WO2008114125A1 Compositions containing compounds having steroid structure and their use for inducing the proliferation and differentiation of stem cells of the organism |
| 09/25/2008 | WO2008114123A1 Spiro benzimidazole derivatives as acid pump inhibitors |
| 09/25/2008 | WO2008114114A2 Poly(adp-ribose) polymerases inhibitor for treating ophthalmic condition |
| 09/25/2008 | WO2008114054A1 Protease inhibitors |
| 09/25/2008 | WO2008114023A2 Phthalazinone derivatives |
| 09/25/2008 | WO2008114022A1 Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents |
| 09/25/2008 | WO2008114017A2 Compositions and methods relating to influenza infection |
| 09/25/2008 | WO2008114015A2 Isoprenoid compounds, their isolation and use |
| 09/25/2008 | WO2008114009A1 10h-benzo(g)pterdine-2,4-dione compounds for the treatment of proliferative disorders |
| 09/25/2008 | WO2008114008A1 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7 ) modulators |
| 09/25/2008 | WO2008114006A1 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7) modulators |
| 09/25/2008 | WO2008114002A1 Quinoline derivatives for the treatment of inflammatory diseases |
| 09/25/2008 | WO2008113981A1 Antibacterial formulations |
| 09/25/2008 | WO2008113965A1 Indolizine acetic acid derivatives as crth2 antagonists |
| 09/25/2008 | WO2008113929A1 Pharmaceutical composition containing phloroglucinol and paracetamol |
| 09/25/2008 | WO2008113919A1 Low molecular weight heparins including at least one covalent bond with biotin or a biotin derivative, method for making same and use thereof |
| 09/25/2008 | WO2008113918A1 Heparins including at least one covalent bond with biotin or a biotin derivative, method for preparing same and use thereof |
| 09/25/2008 | WO2008113881A1 Compound that is a dual inhibitor of enzymes pde7 and/or pde4, pharmaceutical compositions and uses thereof |
| 09/25/2008 | WO2008113863A2 Nitrosated derivatives of 2,5-dihydroxybenzene compounds |
| 09/25/2008 | WO2008113862A2 Composition useful for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistance |
| 09/25/2008 | WO2008113856A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 09/25/2008 | WO2008113818A1 Use of quinoline derivatives in the treatment of pain and irritable bowel syndrome |
| 09/25/2008 | WO2008113803A1 Hot-melt micropellets |
| 09/25/2008 | WO2008113795A1 Compounds which potentiate ampa receptor and uses thereof in medicine |
| 09/25/2008 | WO2008113760A2 Arylsulphonyglycine derivatives as suppressors of the interaction of glycogen phosphorylase a with the gl subunit of glycogen-associated protein phosphatase 1 (ppl) for the treatment of metabolic disorders, particulary diabetes |
| 09/25/2008 | WO2008113756A2 Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors |
| 09/25/2008 | WO2008113747A1 Medicaments useful as potassium channel modulators |
| 09/25/2008 | WO2008113711A1 Substituted pyrimidodiazepines useful as plk1 inhibitors |
| 09/25/2008 | WO2008113686A2 Photoreactive ru (ii) complexes anchored on oligonucleotides, method for obtaining them and use thereof |
| 09/25/2008 | WO2008113558A1 Amino-naphthyridine derivatives |
| 09/25/2008 | WO2008113500A1 Methods and compounds for modulating inflammatory processes |
| 09/25/2008 | WO2008113469A2 Substituted imidazopyrimidines and triazolopyrimidines |
| 09/25/2008 | WO2008113456A1 Tetrahydroquinoline derivatives and use of same for treating cancer |
| 09/25/2008 | WO2008113452A1 Substituted tetrahydropyrroloquinolines |
| 09/25/2008 | WO2008113451A1 Substituted tetrahydroquinolines |
| 09/25/2008 | WO2008113450A2 Use of chroman-4-on-derivatives |
| 09/25/2008 | WO2008113421A1 New pharmaceutical compositions for lipolysis and method for the production thereof |
| 09/25/2008 | WO2008113400A1 Preparations for the topical treatment of skin diseases |
| 09/25/2008 | WO2008113364A2 Amino derivatives to prevent nephrotoxicity and cancer |
| 09/25/2008 | WO2008113360A2 4- [2- (4-methylphenylsulfanyd-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of adhd, melancholia, treatment resistent depression or residual symptoms in depression |
| 09/25/2008 | WO2008113359A2 1- [2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition |
| 09/25/2008 | WO2008113358A1 Liquid formulations of salts of 4-[2-(4-methylphenylsulfanyl)phenyl]piperidine |
| 09/25/2008 | WO2008113320A1 Lejimalid analoga and uses thereof |
| 09/25/2008 | WO2008113255A1 Benzamide derivatives with anti-proliferative activity, pharmaceutical preparations thereof |
| 09/25/2008 | WO2008113177A1 Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof |
| 09/25/2008 | WO2008113161A1 Phosphate prodrugs of quinazolinyl nitrofurans, methods of obtaining, and use of same |
| 09/25/2008 | WO2008113149A2 Observations where certain claims were found unsearchable |
| 09/25/2008 | WO2008113144A1 Nanoparticulated anesthetic composition for topic use |
| 09/25/2008 | WO2008113115A1 Body fluid supplement composition and uses thereof |
| 09/25/2008 | WO2008113114A1 Body fluid supplement compositions and their use in subjects undergoing medical treatment |
| 09/25/2008 | WO2008113100A1 Method for inducing autophagy |
| 09/25/2008 | WO2008113095A1 Compositions and therapies comprising tranilast compounds and angiotensin-converting enzyme (ace) inhibitors and/or angiotensin receptor blockers (arb) |
| 09/25/2008 | WO2008113089A1 Pleuromutilin derivatives for the treatment of diseases mediated by microbes |
| 09/25/2008 | WO2008097428A3 Compounds and compositions as modulators of gpr119 activity |
| 09/25/2008 | WO2008096021A3 Process for continuous production of lovastatine |
| 09/25/2008 | WO2008094574A3 Furanone compounds and methods of making and using the same |
| 09/25/2008 | WO2008094556A3 Imidazolone compounds as tgf-beta family type i receptors, alk5 and/or alk4 antagonists |
| 09/25/2008 | WO2008094379A3 Methods for treatment of pulmonary fibrosis |
| 09/25/2008 | WO2008093303A3 Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts |
| 09/25/2008 | WO2008092219A3 Pharmaceutical composition comprising tramadol and ketoprofen |
| 09/25/2008 | WO2008092103A3 Combination cancer treatments comprising elsamitrucin and other agents |
| 09/25/2008 | WO2008091624A3 Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof |
| 09/25/2008 | WO2008091540A3 23-substituted bile acids as tgr5 modulators and methods of use thereof |
| 09/25/2008 | WO2008086971A3 β-LACTAM-CONTAINING FORMULATIONS HAVING INCREASED STABILITY IN AQUEOUS SOLUTION |
| 09/25/2008 | WO2008086128A3 Aminopyrazole kinase inhibitors |
| 09/25/2008 | WO2008085728A3 Combination medication for treating the effects of stomach acid reduction medication on bone integrity |
| 09/25/2008 | WO2008084319A3 Novel nucleic acid |
| 09/25/2008 | WO2008083398A3 Intermediate useful in preparing certain pyrrolotriazine compounds and a process for making the intermediate |
| 09/25/2008 | WO2008081175A3 Method of producing a composition from an oleogel and an aqueous gel and the composition |
| 09/25/2008 | WO2008077810A3 Spiro-piperidine derivatives |
| 09/25/2008 | WO2008070477A3 Polymeric short interfering rna conjugates |
| 09/25/2008 | WO2008070264A3 Nasal spray composition and method for treating rhinitis, sinusitis or both |
| 09/25/2008 | WO2008067399A3 Controlled-release multi-layer formulation of piperazine-piperidine antagonists and agonists of the 5-th1a receptor having enhanced intestinal dissolution |
| 09/25/2008 | WO2008066729A3 Boronic acid containing compositions |
| 09/25/2008 | WO2008062466A3 Cinnamic acid, vanillic acid and benzofuran derivatives for use in the treatment of inflammation and cancer |
| 09/25/2008 | WO2008061238A3 Processes for production of 4-biphenylyazetidin-2-ones |
| 09/25/2008 | WO2008060391A3 2- [l-phenyl-5-hydr0xy-4alpha-methyl-hexahydr0cycl0penta[f] indaz0l-5-yl] ethyl phenyl derivatives as glucocorticoid receptor ligands |
| 09/25/2008 | WO2008055249A3 Butyrylcholinesterase inhibitors and their use in the treatment of neurodegenerative diseases |
| 09/25/2008 | WO2008052088A8 Chromane derivatives, synthesis thereof, and intermediates thereto |
| 09/25/2008 | WO2008051586A3 Anti-resorptive and bone building dietary supplements and methods of use |
| 09/25/2008 | WO2008047082A3 Polymorphic form of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-one |
| 09/25/2008 | WO2008046919A3 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors |
| 09/25/2008 | WO2008034119A3 Polyalkylene oxides having hindered ester-based biodegradable linkers |
| 09/25/2008 | WO2008031631A3 Oral modified release formulations |